Lycia Therapeutics, Inc. — Form 4
Filed October 28, 2026 · analyzed by the Insider Agent
4
— Neutral
significance 20/100
What the filing says
10% owner Versant Ventures VII GP, L.P. (LYCA) disposed 31.7M shares (non-open-market). Non-market disposition.
Why this rating
Non-market disposition.
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.